# Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

> **NCT03126760** · PHASE4 · TERMINATED · sponsor: **Mallinckrodt ARD LLC** · enrollment: 35 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Acthar Gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03126760
- **Lead sponsor:** Mallinckrodt ARD LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-22
- **Primary completion:** 2020-07-14
- **Final completion:** 2020-07-14
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Recruitment difficulties and COVID-19 logistical challenges; no safety concerns
- **Last updated:** 2021-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03126760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03126760, "Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03126760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*